Valuation: DiaSorin S.p.A.

Market Cap 3.77B 4.33B 3.57B 3.25B 6.06B 415B 6.09B 42.55B 16.45B 211B 16.28B 15.92B 675B P/E 2026 *
22.1x
P/E 2027 * 19.5x
Enterprise Value 4.48B 5.15B 4.24B 3.85B 7.2B 493B 7.23B 50.52B 19.53B 250B 19.33B 18.9B 802B EV / Sales 2026 *
3.63x
EV / Sales 2027 * 3.29x
Free-Float
37.17%
Yield 2026 *
1.71%
Yield 2027 * 1.78%
1 day+1.23%
1 week+5.18%
Current month+1.74%
1 month+4.72%
3 months+21.12%
6 months+21.12%
Current year+12.50%
1 week 73.14
Extreme 73.14
77.28
1 month 72.7
Extreme 72.7
77.5
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
80.38
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
205.9
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/03/26 Buy

Chief Executive Officer

9,211 0.0165%
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%+5.18%-2.28%-15.13% 4.33B
+4.69%+15.14%+220.16%+520.05% 24.57B
+0.55%+2.98%-36.35%-20.68% 9.74B
+5.90%+15.95%+498.52%+54.78% 10.03B
+9.61%+28.62%-7.78% - 8.74B
+0.26%+0.41%+98.27%+55.53% 6.58B
+0.22%+1.87%-29.50%-24.49% 5.75B
+0.95%-3.17%+53.60%+64.65% 3.78B
+0.78%+0.09%-21.43%-30.67% 2.74B
-1.19%-11.70% - - 1.55B
Average +2.30%+5.31%+85.91%+75.50% 7.78B
Weighted average by Cap. +3.55%+10.25%+138.96%+199.12%

Financials

2026 *2027 *
Net sales 1.23B 1.42B 1.17B 1.06B 1.98B 136B 1.99B 13.92B 5.38B 68.98B 5.32B 5.21B 221B 1.31B 1.5B 1.24B 1.13B 2.11B 144B 2.12B 14.77B 5.71B 73.23B 5.65B 5.53B 234B
Net income 183M 210M 173M 157M 294M 20.12B 295M 2.06B 798M 10.23B 789M 772M 32.74B 206M 236M 195M 177M 330M 22.61B 332M 2.32B 896M 11.49B 887M 867M 36.78B
Net Debt 707M 811M 669M 608M 1.14B 77.69B 1.14B 7.97B 3.08B 39.48B 3.05B 2.98B 126B 542M 622M 513M 466M 871M 59.59B 875M 6.11B 2.36B 30.28B 2.34B 2.29B 96.95B
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
18/09/26 77.24 +1.29% 58,864
17/09/26 €76.26 +1.30% 288,055
16/09/26 €75.28 +1.48% 145,848
15/09/26 €74.18 +0.38% 132,601
14/09/26 €73.90 +0.68% 127,118
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
76.26EUR
Average target price
72.81EUR
Spread / Average Target
-4.53%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!